Fiona Angela Marston
Direttore/Membro del Consiglio presso Biotechnology & Biological Sciences Research Council
Profilo
Fiona Angela Olinda Marston is the founder of Novacta Biosystems Ltd.
She currently holds director positions at Biotechnology & Biological Sciences Research Council and Erebagen Ltd.
Previously, she served as the CEO of Absynth Biologics Ltd.
and as a non-executive director at Medella Therapeutics Ltd.
She also worked as a senior investment manager at H2O Venture Partners Ltd.
from 2008 to 2011.
Dr. Marston received her undergraduate degree from the University of East Anglia, her MBA from London Business School, and her doctorate from the University of Kent.
Posizioni attive di Fiona Angela Marston
Società | Posizione | Inizio |
---|---|---|
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Direttore/Membro del Consiglio | - |
Erebagen Ltd.
Erebagen Ltd. BiotechnologyHealth Technology Erebagen Ltd. is a British company founded in 2020 that develops novel bioactive products from microbes by activating previously silent gene clusters. The company is based in Coventry, UK. | Direttore/Membro del Consiglio | 01/04/2022 |
Precedenti posizioni note di Fiona Angela Marston
Società | Posizione | Fine |
---|---|---|
H2O Venture Partners Ltd.
H2O Venture Partners Ltd. Investment ManagersFinance H2O Venture Partners Ltd (H2O Venture Partners) is a private equity subsidiary of H20 Venture Partners (Manager) LLP founded in 2006 by David Kelly and Coleman Paul. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | 01/07/2011 |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Amministratore Delegato | - |
Medella Therapeutics Ltd.
Medella Therapeutics Ltd. BiotechnologyHealth Technology Medella Therapeutics Ltd. develops monoclonal antibody drugs for cancer. Its focus is on cancer, where the unmet need is for therapies that preferentially target cell signaling in cancer cells, offering advantages over drugs marketed and in clinical development. The company was founded by Kim Skerry and Gareth Richards in May 2007 and is headquartered in Sheffield, the United Kingdom. | Direttore/Membro del Consiglio | - |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Fondatore | - |
Formazione di Fiona Angela Marston
University of Kent | Doctorate Degree |
London Business School | Masters Business Admin |
University of East Anglia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
Medella Therapeutics Ltd.
Medella Therapeutics Ltd. BiotechnologyHealth Technology Medella Therapeutics Ltd. develops monoclonal antibody drugs for cancer. Its focus is on cancer, where the unmet need is for therapies that preferentially target cell signaling in cancer cells, offering advantages over drugs marketed and in clinical development. The company was founded by Kim Skerry and Gareth Richards in May 2007 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
H2O Venture Partners Ltd.
H2O Venture Partners Ltd. Investment ManagersFinance H2O Venture Partners Ltd (H2O Venture Partners) is a private equity subsidiary of H20 Venture Partners (Manager) LLP founded in 2006 by David Kelly and Coleman Paul. The firm is headquartered in London, United Kingdom. | Finance |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Health Technology |
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Commercial Services |
Erebagen Ltd.
Erebagen Ltd. BiotechnologyHealth Technology Erebagen Ltd. is a British company founded in 2020 that develops novel bioactive products from microbes by activating previously silent gene clusters. The company is based in Coventry, UK. | Health Technology |
- Borsa valori
- Insiders
- Fiona Angela Marston